Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
about
SRChing for the substrates of Src.Requirement of PEA3 for transcriptional activation of FAK gene in tumor metastasis.Kinases as targets for chemical modulators: Structural aspects and their role in spermatogenesis.FAK is overexpressed in keratocystic odontogenic tumor: a preliminary study.Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns.Focal adhesion kinase inhibitor PF573228 and death receptor 5 agonist lexatumumab synergistically induce apoptosis in pancreatic carcinoma.Emerging roles of focal adhesion kinase in cancer.Monitoring focal adhesion kinase phosphorylation dynamics in live cells.Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer.
P2860
Q30457060-03F89BA3-D051-45FE-9E79-D12AC44BC955Q35048351-62355C3C-89E5-48A2-A088-9781F9692331Q36088077-D17DCE76-1F19-4FF9-BCBC-6EC8CCEB8370Q36217314-DA61BAB0-797E-4406-923E-71A6ECC3D593Q36283299-136FA5D9-B9CC-4E59-8822-7A33AA71CD96Q37100734-28A7B249-4767-43D1-BA98-F0890FDF7568Q38239003-5272F55B-4046-4209-8677-D5E944FDA2D3Q38269966-8045D693-C569-4E66-89E1-A5CC94A94507Q38705400-BB50C48A-AC42-47BA-BEBD-49719C94B34DQ39611596-B54F68CF-2128-4AB0-BFC5-095002E33596Q48314829-65A9651F-3950-4C00-96BE-CA5147A8105CQ54472346-A7BDD2B2-12E8-49AA-8BCB-DBB35FE7875F
P2860
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2010
@uk
name
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
@en
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
@nl
type
label
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
@en
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
@nl
prefLabel
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
@en
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
@nl
P2093
P1476
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
@en
P2093
Kelli Bullard Dunn
Melissa Heffler
Vita M. Golubovskaya
P304
P356
10.2174/187152010794728657
P577
2010-12-01T00:00:00Z